Publications by authors named "Dominic Surry"

Claim this Profile
E
Effects of Fostamatinib on the Pharmacokinetics of the CYP2C8 Substrate Pioglitazone: Results From In Vitro and Phase 1 Clinical Studies.
Paul Martin, Michael Gillen, David Millson, Stuart Oliver, Clive Brealey, Dominic Surry

Clin Pharmacol Drug Dev· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure.
Robert Elsby, Paul Martin, Dominic Surry, Pradeep Sharma, Katherine Fenner

Drug Metab Dispos· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of proteins by flow cytometry: Quantification of human hepatic transporter P-gp and OATP1B1 using flow cytometry and mass spectrometry.
Karen Hogg, Jerry Thomas, David Ashford, Jared Cartwright, Ruth Coldwell, Dominic Surry

Methods· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of bioreactors as in vitro models in pharmaceutical research.
Maaria Ginai, Robert Elsby, Christopher J Hewitt, Dominic Surry, Katherine Fenner

Drug Discov Today· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins.
Pradeep Sharma, Caroline J Butters, Veronica Smith, Robert Elsby, Dominic Surry

Eur J Pharm Sci· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.
Robert Elsby, Veronica Smith, Lisa Fox, David Stresser, Caroline Butters, Dominic D Surry

Xenobiotica· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro risk assessment of AZD9056 perpetrating a transporter-mediated drug-drug interaction with methotrexate.
Robert Elsby, Lisa Fox, David Stresser, Mark Layton, Caroline Butters, Dominic Surry

Eur J Pharm Sci· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672.
Robert Elsby, Michael Gillen, Caroline Butters, Gemma Imisson, Pradeep Sharma, Dominic D Surry

Drug Metab Dispos· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.
Roger J Gillespie, Samantha J Bamford, Ruth Botting, Mike Comer, Sarah Denny, Dominic Surry

J Med Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray.
Françoise de Longueville, Dominic Surry, Georgina Meneses-Lorente, Vincent Bertholet, Valérie Talbot

Biochem Pharmacol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis